10
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Regional Management of Liver Metastases. I

Pages 237-257 | Published online: 11 Jun 2009

References

  • Abrams HL, Spiro R, Goldstein N. Metastases in carcinoma: Analysis of 1000 autopsied cases. Cancer 1950; 3: 74–85
  • Bross I DJ, Viadana E, Pickren J. Do generalized metastases occur directly from the primary?. J Chron Dis 1975; 28: 149–159
  • Jaffee BM, Donegan WL, Watson F, et al. Factors influencing survival in patients with untreated hepatic metastases. Surg Gyn Obstet 1968; 127: 1–11
  • Fishcherman K, Peterson CF, Lindkaer-Jensen S, et al. Survival among patients with liver metastasis from cancer of the colon and rectum. Scand J Gastroenterol (Suppl) 1976; 37: 111–115
  • Rapoport AH, Burleson RL. Survival of patients treated with systemic fluorouracil for hepatic metastases. Surg Gyn Obstet 1970; 130: 773–777
  • Moertel CG. Gastrointestinal cancer, treatment with fluorouracil nitrosourea combinations. J Am Med Assoc 1976; 235: 2135–2136
  • Priestman TJ, Hanham I WF. Results of 27 cases with hepatic metastases treated by combination chemotherapy. Br J Cancer 1972; 26: 466–472
  • Welch JP, Donaldson GA. The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg 1979; 189: 496–502
  • Cady B, Monson DO, Swinton NW. Survival of patients after colonic resection for carcinoma with simultaneous liver metastasis. Surg Gyn Obstet 1970; 131: 697–700
  • Bengtsson G, Carlsson G, Hafstron L, et al. Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 1981; 141: 586–589
  • Foster JH. Survival after liver resection for secondary tumors. Am J Surg 1978; 135: 389–394
  • Stehlin JS, Hafstrom L, Greeff PJ. Experience with infusion and resection in cancer of the liver. Surg Gyn Obstet 1974; 138: 855–863
  • Hagemeister FB, Jr, Buzdar AU, Luna MA, et al. Causes of death in breast cancer: A clinicopathologic study. Cancer 1980; 46: 162–167
  • Viadana E, Cotter R, Pickren JW, et al. An autopsy study of metastatic sites of breast cancer. Cancer Res 1973; 33: 179–181
  • Lee Y-TN. Malignant melanoma: Pattern of metastases. Ca-A Cancer J Clin 1980; 30: 137–142
  • Nielsen J, Balslev I, Jenssen HE. Carcinoma of the colon with liver metastases: Operative indications and prognosis. Acta Chir Scand 1971; 137: 463
  • Baden H, Andersen B. Survival of patients with untreated liver metastases from colorectal cancer. Scand J Gastroenterol 1975; 10: 221–223
  • Bengmark S, Hafstrom L. The natural course for liver cancer. Prog Clin Cancer 1978; 7: 195–200
  • Boey J, Choi TK, Wong J, et al. Carcinoma of the colon and rectum with liver involvement. Surg Gyn Obstet 1981; 153: 864–868
  • Wanebo HJ, Semoglou C, Attiyeh F, et al. Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. Am J Surg 1978; 135: 81–85
  • Bengmark S, Hafstrom L. The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastasis from colonic and rectal carcinoma by laparotomy. Cancer 1969; 23: 198–202
  • Wood CB, Gillis CR, Blumgart LH. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 1976; 2: 285–288
  • Pettavel J, Morgenthaler F. Protracted arterial chemotherapy of liver tumors: An experience of 107 cases over a 12-year period. Prog Clin Cancer 1978; 7: 217–233
  • Ariel IM, Pack GT. Treatment of inoperable cancer of the liver by intra-arterial radioactive isotopes and chemotherapy. Cancer 1967; 20: 793–804
  • Cady B, Oberfield RA. Regional infusion chemotherapy of hepatic metastases from carcinoma of the colon. Am J Surg 1974; 127: 220–227
  • Almersjo O, Bengmark S, Hafstrom L, et al. Results of liver dearterialization combined with regional infusion of 5-fluo-rouracil for liver cancer. Acta Chir Scand 1976; 142: 131–138
  • Nagasue N, Inokuchi K, Kobayashi M, et al. Hepatic dearterialization for nonresectable primary and secondary tumors of the liver. Cancer 1976; 38: 2593–2603
  • El-Domeiri AA. Treatment of hepatic metastases in cancer of the colon and rectum; A preliminary report. Cancer 1980; 45: 2245–2248
  • Former JG, Maclean BJ, Kim DK, et al. The seventies evolution in liver surgery for cancer. Cancer 1981; 47: 2162–2166
  • Oberfield RA, McCaffrey Ja, Polio J, et al. Prolonged and continuous percutaneous intra-arterial hepatic infusion chemotherapy in advanced metastatic liver adenocarcinoma from colorectal primary. Cancer 1979; 44: 414–423
  • Wilson SM, Adson MA. Surgical treatment of hepatic metastases from colorectal cancers. Arch Surg 1976; 111: 330–334
  • Lavin P, Mittelman A, Douglass H, et al. Survival and response to chemotherapy for advanced colorectal adenocarcinoma: An Eastern Cooperative Oncology Group Report. Cancer 1980; 46: 1536–1543
  • Watkins E, Khazei AM, Nahra KS. Surgical basis for arterial infusion chemotherapy of disseminated carcinoma of the liver. Surg Gyn Obstet 1970; 130: 581–605
  • Reed ML, Vaitkevicius VK, Al-Sarraf M, et al. The practicality of chronic hepatic artery infusion therapy of primary and metastatic hepatic malignancies: Ten-year results of 124 patients in a prospective protocol. Cancer 1981; 47: 402–409
  • Attiyeh FF, Wanebo HJ, Stearns MW. Hepatic resection for metastasis from colorectal cancer. Dis Colon Rectum 1978; 21: 160–162
  • Grage TB, Shingleton WW, Jubert AV, et al. Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracil vs. intravenous 5-fluorouracil in patients with hepatic metastases from colo-rectal cancer: A Central Oncology Group Study (COG 7032). Front Gastrointest Res 1979; 5: 116–129
  • Raven RW. Hepatectomy XVI Congres de la Societe Internationale de Chirurgie. Imprimerie Med-icale et Scientifique, Copenhagen, Brussels 1955; 1099
  • Smith R. Tumours of the liver (Bradshaw Lecture, 1977). Ann College Surg Eng 1979; 61: 87–99
  • Fortner JG, Papachristou DN. Surgery of liver tumors. Int Adv Surg Oncol 1979; 2: 251–275
  • Brunschwig A. Hepatic lobectomy for metastaic cancer. Cancer 1963; 16: 277
  • Muhe E, Gall FP, Angermann B. Surgical treatment of metastases to the lung and liver. Surg Gyn Obstet 1981; 152: 211–214
  • Almersjo O, Bengmark S, Hafstrom L. Liver resection for cancer. Acta Chir Scand 1976; 142: 139–144
  • McBride CM, Wallace S. Cancer of the right lobe of the liver. Arch Surg 1972; 105: 289–296
  • Fortner JG, Kim DK, Maclean BJ, et al. Major hepatic resection for neoplasia: Personal experience in 108 patients. Ann Surg 1978; 188: 363–370
  • Hanks JB, Meyers WC, Filston HC, et al. Surgical resection for benign and malignant liver disease. Ann Surg 1980; 191: 584–590
  • Miller TR. End results in the surgical treatment of liver tumors. Tumors of the Liver, GT Pack, AH Islami. Springer-Verlag, New York 1970; 293–298
  • Flanagan L, Foster JH. Hepatic resection for metastatic cancer. Am J Surg 1967; 113: 551–557
  • Adson MA, VanHeerden JA. Major hepatic resections for metastatic colorectal cancer. Ann Surg 1980; 191: 576–583
  • Foster JH, Lundy J. Liver metastases. Cur Prob Surg 1981; 18: 1–202
  • Fortner JG, Shiu MH, Kinne DW, et al. Major hepatic resection using vascular isolation and hypothermic perfusion. Ann Surg 1974; 180: 644–650
  • Bierman HR, Byron RL, Miller ER, et al. Effects of intraarterial administration of nitrogen mustard. Am J Med 1950; 8: 535
  • Klopp CT, Bateman J, Berry N, et al. Fractionated regional cancer chemotherapy. Cancer Res 1950; 10: 229
  • Sullivan RD, Miller E, Sikes MP. Antimetabolite-metabolite combination cancer chemotherapy. Cancer 1959; 12: 1248–1261
  • Clarkson B, Young C, Dierick E, et al. Effects of continuous hepatic artery infusion of antimetabolites on primary and metastatic cancer of the liver. Cancer 1962; 15: 472
  • Brennan MJ, Talley RW, Drake EH, et al. 5-Fluorouracil treatment of liver metastases by continuous hepatic artery infusion via Cournand catheter. Ann Surg 1963; 158: 405–419
  • Ansfield FJ, Ramirez G, Skibba JL, et al. Intrahepatic arterial infusion with 5-fluorouracil. Cancer 1971; 28: 1147–1151
  • Ansfield FJ, Ramirez G. The clinical results of 5-fluorouracil intrahepatic arterial infusion in 528 patients with metastatic cancer to the liver. Prog Clin Cancer 1978; 7: 201–206
  • Ansfield FJ, Ramirez G, Davis HL, et al. Further clinical studies with intrahepatic arterial infusion with 5-fluorouracil. Cancer 1975; 36: 2413–2417
  • Chuang VP, Wallace S. Current status of transcatheter management of neoplasms. Cardiovasc Intervent Radiol 1980; 3: 256–265
  • Petrek JA, Minton JP. Treatment of hepatic metastases by percutaneous hepatic arterial infusion. Cancer 1979; 43: 2182–2188
  • Karakousis CP, Douglass HO, Holyoke ED. Technique of infusion chemotherapy, ligation of the hepatic artery and dearterialization in malignant lesions of the liver. Surg Gyn Obstet 1979; 149: 403–407
  • Labelle JJ, Lucas RJ, Eisenstein B, et al. Hepatic artery catheterization for chemotherapy. Arch Surg 1968; 96: 683–693
  • Watkins E, Oberfield RA, Cady B, et al. Arterial infusion chemotherapy of diffuse hepatic malignancies. Prog Clin Cancer 1978; 7: 235–245
  • Freckman HA. Chemotherapy for metastatic colorectal liver carcinoma by intra-aortic infusion. Cancer 1971; 28: 1152–1160
  • Sundqvist K, Hafstrom LO, Jonsson PE, et al. Treatment of liver cancer with regional intra-arterial 5-FU infusion. Am J Surg 1978; 136: 328–331
  • Sullivan RD, Zurek WZ. Chemotherapy for liver cancer by protracted ambulatory infusion. J Am Med Assoc 1965; 194: 481–486
  • Clouse ME, Ahmed R, Ryan RB, et al. Complications of long term transbrachial hepatic arterial infusion chemotherapy. Am J Roentgenol 1977; 129: 799–803
  • Maki DG, McCormick RD, Uman SJ, et al. Septic endarteritis due to intra-arterial catheters for cancer chemotherapy. Cancer 1979; 44: 1228–1240
  • Sullivan RD. Systemic and arterial infusion chemotherapy for metastatic liver cancer. Int J Rad Oncol Biol Phys 1976; 1: 973–976
  • Fortuny IE, Theologides A, Kennedy BJ. Hepatic arterial infusion for liver metastases from colon cancer: Comparison of mitomycin C (NSC-26980) and 5-fluorouracil (NSC-19893). Cancer Chemother Rep 1975; 59: 401–404
  • Narsete T, Ansfield F, Wirtanen G, et al. Gastric ulceration in patients receiving intrahepatic infusion of 5-fluorouracil. Ann Surg 1977; 186: 734–736
  • Chuang VP, Wallace S, Stroehlein J, et al. Hepatic artery infusion chemotherapy: Gastroduodenal complications. Am J Roentgenol 1981; 137: 347–350
  • Buchwald H, Grage TB, Vassilopoulos PP, et al. Intraarterial infusion chemotherapy for hepatic carcinoma using a totally implantable infusion pump. Cancer 1980; 45: 866–869
  • Cohen AM, Wood WC, Greenfield A, et al. Transbrachial hepatic arterial chemotherapy using an implanted infusion pump. Dis Colon Rectum 1980; 23: 223–227
  • Ensminger W, Niederhuber J, Dakhil S, et al. Totally implanted drug delivery system for hepatic arterial chemotherapy. Cancer Treat Rep 1981; 65: 393–400
  • Former JG, Mulcare RJ, Solis A, et al. Treatment of primary and secondary liver cancer by hepatic artery ligation and infusion chemotherapy. Ann Surg 1973; 178: 162–171
  • Gorgun B, Watne AL. Infusion chemotherapy in hepatoma and metastatic liver tumors. Am J Surg 1967; 113: 363–368
  • Herter FP, Markowitz AM, Feind CR. Cancer chemotherapy by continuous intraarterial infusion of antimetabolites. Am J Surg 1963; 105: 628–639
  • Bengmark S, Rosengren K. Angiographic study of the collateral circulation to the liver after ligation of the hepatic artery in man. Am J Surg 1970; 119: 620–624
  • Burrows JH, Talley RW, Drake EL, et al. Infusion of fluorinated pyrimidines into hepatic artery for treatment of metastatic carcinoma of the liver. Cancer 1967; 20: 1886–1892
  • Leone LA. The chemotherapy of colorectal. Cancer 1974; 34: 972–976
  • Ensminger WD, Rosowsky A, Raso V, et al. A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2-deoxyuridine and 5-fluorouracil. Cancer Res 1978; 38: 3784–3792
  • Patt YZ, Chuang VP, Wallace S, et al. The palliative role of hepatic arterial infusion and arterial occlusion in colorectal carcinoma metastatic to the liver. Lancet 1981; 1: 349–350
  • Tylen U, Dahl E, Fredlung P. Angiography after temporary inhibition of blood flow followed by intra-arterial 5-FU infusion in the treatment of liver metastases. Acta Radiol Diag 1981; 22: 15–23
  • Kim DK, McSweeney J, Yeh S DJ, et al. Tumors of the liver as demonstrated by angiography, scan and laparotomy. Surg Gyn Obstet 1975; 141: 409–410
  • Davis HL, Ramirez G, Ansfield FJ. Adenocarcinomas of stomach, pancreas, liver and biliary tracts. Cancer 1974; 33: 193–197
  • Ansfield F, Klotz J, Nealon T, et al. A phase III study comparing the clinical utility of four regimens of 5-fluorouracil: A preliminary report. Cancer 1977; 39: 34–40
  • Rochlin DB, Smart CR. An evaluation of 51 patients with hepatic artery infusion. Surg Gyn Obstet 1966; 123: 535–538
  • Tandon RN, Bunnell IL, Copper RG. The treatment of metastatic carcinoma of the liver by the percutaneous selective hepatic artery infusion of 5-fluorouracil. Surgery 1973; 73: 118–121
  • Massey WH, Fletcher WS, Judkins MP, et al. Hepatic artery infusion for metastatic malignancy using percutaneously placed catheters. Am J Surg 1971; 121: 160–164
  • Kraybill WG, Harrison M, Sasaki T, et al. Regional intraarterial infusion of adriamycin in the treatment of cancer. Surg Gyn Obstet 1977; 144: 335–338
  • Douglass CC. Improved survival in liver metastases from colorectal carcinoma following periodic arterial infusions with mitomycin-C, 5-fluorouracil, adriamycin, velban, and vincristine. Proc Am Soc Clin Oncol 1979; 20: 431
  • Robison EW. Metastatic liver disease; treatment by hepatic artery infusion. Rocky Mt Med J 1979; 76: 185–186
  • Calvo DB, Patt YZ, Wallace S, et al. Phase III trial of percutaneous intra-arterial cisdiamminedichloro-platinum (II) for regionally confined malignancy. Cancer 1980; 45: 1278–1283
  • Helsper JT, Lance JS, Hall TC. Transfemoral hepatic artery infusion for metastatic carcinoma. J Surg Oncol 1981; 18: 173–181
  • Donegan WL, Harris HS. Metastatic colorectal carcinoma—Response to hepatic infusion. Missouri Med 1970; 67: 163–168
  • Donegan WL, Harris HS, Spratt JS. Prolonged continuous hepatic infusion. Arch Surg 1969; 99: 149–157
  • Misra NC, Jaiswal M SD, Singh RV, et al. Intrahepatic arterial infusion of combination of mitomycin-C and 5-fluorouracil in treatment of primary and metastatic liver carcinoma. Cancer 1977; 39: 1425–1429
  • Patt YZ, Wallace S, Hersh EM, et al. Hepatic arterial infusion of corynebacterium parvum and chemotherapy. Surg Gyn Obstet 1978; 147: 897–902
  • Patt YZ, Mavligit GM, Chuang VP, et al. Percutaneous hepatic arterial infusion (HAI) of mtomycin-C and floxuridine (FUDR): An effective treatment for metastatic colorectal carcinoma in the liver. Cancer 1980; 46: 261–265
  • Kondi ES, Gallitano AL, Evjy JT, et al. Prolonged survival in patients with hepatic malignant melanoma treated by intraarterial bleomycin and later oral hydroxyurea. Am J Surg 1974; 128: 85–87
  • Kinami Y, Miyazaki I. The superselective and the selective one shot methods for treating inoperable cancer of the liver. Cancer 1978; 41: 1720–1727
  • Tilchen E, Patt YZ, McBride CM, et al. Sequence of regional chemotherapy and surgery. Arch Surg 1981; 116: 959–960
  • Grage TB, Vassilopoulos PP, Shingleton WW, et al. Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracil versus intravenous 5-fluorouracil in patients with hepatic metastases from colorectal cancer: A Central Oncology Group study. Surgery 1979; 86: 550–555
  • Madding GF, Kennedy PA. Hepatic artery ligation. Surg Clin N Am 1972; 52: 719–728
  • Segal HN. An experimental anatomical investigation of bile channels in the liver. Surg Gyn Obstet 1923; 37: 152–178
  • Markowitz J. The hepatic artery. Surg Gyn Obstet 1952; 95: 644–646
  • Lee Y-TN. Nonsystemic treatment of metastatic tumors of the liver—A review. Med Ped Oncol 1978; 4: 185–203
  • Nilsson L AV. Therapeutic hepatic artery ligation in patients with secondary liver tumors. Rev Surg September-October, 1966; 374–376
  • Almersjo O, Bengmark S, Engevik L, et al. Serum enzyme changes after hepatic dearterialization in man. Ann Surg 1968; 167: 9
  • DeLorimier AA, Simpson EB, Baum RS, et al. Hepatic artery ligation for hepatic hemangiomatosis. New Eng J Med 1967; 277: 333–336
  • Madding GF, Kennedy PA, Sogemeier E. Hepatic artery ligation for metastatic tumor in the liver. Am J Surg 1970; 120: 94–96
  • Murray-Lyon IM, Dawson JL, Parsons VA, et al. Treatment of secondary hepatic tumours by ligation of hepatic artery and infusion of cytotoxic drugs. Lancet 1970; 2: 172–175
  • Aune S, Schistad G. Carcinoid liver metastases treated with hepatic dearterialization. Am J Surg 1972; 123: 715–717
  • Koudahl G, Funding J. Hepatic artery ligation in primary and secondary hepatic cancer. Acta Chir Scand 1972; 138: 289–291
  • Larmi T KI, Karkola P, Klintrup H, et al. Treatment of patients with hepatic tumors and jaundice by ligation of the hepatic artery. Arch Surg 1974; 108: 178–181
  • Zike WL, Safaie-Shirazi S, Gulesserian HP, et al. Hepatic artery ligation and cytotoxic infusion in treatment of liver neoplasms. Arch Surg 1975; 110: 641–643
  • Cuschieri A, Swain C. Hepatic artery ligation and prolonged cytotoxic therapy in advanced primary and secondary liver tumours. Proc Soc Med 1975; 68: 678–680
  • Sparks FC, Mosher MB, Hallauer WC, et al. Hepatic artery ligation and postoperative chemotherapy for hepatic metastases: Clinical and pathophysiological results. Cancer 1975; 35: 1074–1082
  • Ramming KP, Sparks FC, Eilber FR, et al. Hepatic artery ligation and 5-fluorouracil infusion for metastatic colon carcinoma and primary hepatoma. Am J Surg 1976; 132: 236–242
  • Almersjo O, Bengmark S, Rudenstam CM, et al. Evaluation of hepatic dearterialization in primary and secondary cancer of the liver. Am J Surg 1972; 124: 5–9
  • McDermott WV, Hensle TW. Metastatic carcinoid to the liver treated by hepatic dearterialization. Ann Surg 1974; 180: 305–308
  • McDermott WV, Paris AL, Clouse ME, et al. Dearterialization of the liver for metastatic cancer: Clinical, angiographic and pathologic observations. Ann Surg 1978; 187: 38–46
  • Lee Y-TN. Hepatic artery ligation and infusion chemotherapy for malignancy of the liver. J Am Med Women's Assoc 1979; 34: 21–39
  • Lee Y-TN, Irwin L. Hepatic artery ligation and adriamycin infusion chemotherapy for hepatoma. Cancer 1978; 41: 1249–1255
  • Evans JT. Hepatic artery ligation in hepatic metastases from colon and rectal malignancies. Dis Colon Rectum 1979; 22: 370–371
  • Berjian RA, Douglass HO, Nava HR, et al. The role of hepatic artery ligation and dearterialization with infusion chemotherapy in advanced malignancies in the liver. J Surg Oncol 1980; 14: 379–387
  • Taylor I. Studies on the treatment and prevention of colorectal liver metastases. Ann R Col Surg Eng 1981; 63: 270–276
  • Taylor I, Rowling J, West C. Adjuvant cytotoxic liver perfusion for colorectal cancer. Br J Surg 1979; 66: 833–837
  • Ledesma EJ, Evans JT, Yoon J, et al. Indications for cholecystectomy in ligation of the hepatic artery. Surg Gynec Obstet 1981; 152: 451–452
  • Lee Y-TN. Liver function tests after ligation of hepatic artery. J Surg Oncol 1978; 10: 305–320
  • Kim DK, Penneman R, Kallum E, et al. Acute renal failure after ligation of the hepatic artery. Surg Gyn Obstet 1976; 143: 391–394
  • Ong GB. Techniques and therapies for primary and metastatic liver cancer. Current Prob Cancer 1977; 2(6)1–48
  • Kim DK, Kinne DW, Fortner JG. Occlusion of the hepatic artery in man. Surg Gyn Obstet 1973; 136: 966–968
  • Hulten O. Arterialization of the liver in cirrhosis. Scand J Clin Lab Invest 1966; 92: 42–43
  • Reinhoff WG, Jr. Ligation of hepatic and splenic arteries in treatment of portal hypertension with report of 6 cases: Preliminary report. Bull Johns Hopkins Hosp 1951; 88: 368
  • Fortner JG, Kallum BO, Kim DK. Surgical management of hepatic vein occlusion by tumor. Arch Surg 1977; 112: 727–728

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.